A qualitative study on the feasibility and benefits of foot hygiene measures practiced by patients with brugian filariasis

Journal of Communicable Diseases

Volumn 35, Issue 1, 2003, Pages 9-16

  Shenoy, R K ^a   Suma, T K ^a   Kumaraswami, V ^b  

^a TD Medical College Hospital   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Acute adenolymphangitis; Brugian filariasis; Disability; Foot care; Lymphoedema

Indexed keywords

ARTICLE; COMMUNITY CARE; DAILY LIFE ACTIVITY; EVALUATION; FEASIBILITY STUDY; FILARIASIS; FOOT; HAPPINESS; HEALTH CARE; HUMAN; HYGIENE; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PATIENT CARE; PATIENT COUNSELING; QUALITATIVE ANALYSIS; TRAINING;

ANIMALS; BRUGIA MALAYI; ELEPHANTIASIS, FILARIAL; FEASIBILITY STUDIES; HUMANS; LOWER EXTREMITY; SKIN CARE; TREATMENT OUTCOME;

EID: 2542572416     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Michael E, Bundy DAP and Grenfell BT. Reassessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112: 409-428.
2. Ramaiah KD, Das PK, Michael E and Guyatt H. The economic burden of Lymphatic filariasis in India. Parasitol. Today 2000; 16: 251-253.
3. Centers for Disease Control and Prevention (CDC), Atlanta, USA. Recommendations of the International Task Force for Disease Eradication. MMWR 1993; 42: 1-38.
4. Ottesen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Hlth 2000; 5: 591-594.
5. Ottesen EA, Duke BOL, Karam M and Bebehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75: 491-503.
6. Seim AR, Dreyer G and Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Revista da Sociedade Brasileria de Medicina Tropical 1999; 32: 325-328.
7. Dreyer G, Noroes J, Figueredo-Silva and Piessens, W.F. Pathogenesis of lymphatic disease in bancroftian filariasis: A clinical perspective. Parasitol Today 2000; 16: 544-548.
8. Freedman DO, Bui T, de Alemeida Filho PJ, Braga C, Maia e Silva MC, Maciel A and Furtado AF. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 1995; 52: 258-261.
9. Shenoy RK, Sandhya K, Suma TK and Kumaraswami V. A Preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. SE Asian J Trop Med Pub Hlth 1995; 26: 301-305.
10. Addiss DG and Dreyer G. Treatment of lymphatic filariasis. In: TB Nutman (ed). Lymphatic Filariasis, Imperial College Press, London, 2000; 151-199.
11. Pani SP, Yuvaraj J, Vanamail P, Dhanda V, Michael E, Grenfell BT, and Bundy DAP. Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89: 211-214.
12. Shenoy RK, Suma TK, Rajan K and Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 1998; 92: 587-594.
13. Shenoy RK, Kumaraswami V, Suma TK, Rajan K and Radhakuttyamma G. A double blind placebo controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 1999; 93: 367-377.
14. World Health Organization. Lymphatic filariasis: The disease and its control. World Health Organ; 1992. Tech Rep Ser No. 821. Geneva: WHO.
15. Ramaiah KD, Ramu K, Vijayakumar KN and Guyatt H. Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nadu, South India. Trans R Soc Trop Med Hyg 1996; 90: 639-643.
16. Suma TK, Shenoy RK and Kumaraswami, V. Efficacy and sustainability of foot-care programme in preventing acute attacks of adenolymphangitis inbrugian filariasis. Trop Med Int Hlth 2002; 7: 763-766.
17. Pani SP, Krishnamoorthy K, Rao AS and Prathibha J. Clinical manifestations in malayan filariasis infection with special reference to lymphoedema grading. Indian J Med Res 1990; 91: 200-207.
18. Sabesan S, Krishnamoorthy K, Pani SP and Panicker KN. Mandays lost due to repeated acute attacks of lymphatic filariasis. Trends Life Sci 1992; 7: 5-7.
19. McPherson T. Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study. Filaria J 2003; 2: 1-5.
20. Babu BV and Nayak AN. Footcare among lymphoedema patients attending a filariasis clinic in South India: a study of knowledge and practice. Ann Trop Med Parasitol 2003; 97: 321-324.
21. Directotate of Census Operations. Census of India 2001: Kerala: provisional population data sheet. Kerala: Trivandrum. 2001.
22. Ahorlu CK, Dunyo SK, Koram KA, Nkrumah FK, Aagaard-Hansen J and Simonsen PE. Lymphatic filariasis related perceptions and practices on the coast of Ghana: implications for prevention and control. Acta Tropica 1999; 73: 251-264.